Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Cardiff Oncology, Inc.

NASDAQ: CRDF · Life Sciences · 5 alerts · CIK 1213037

Share price
$0.8477Close, Nov 16
Market cap
$65.9M
Shares outstanding
77.8MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cardiff Oncology, Inc. filings on SEC EDGAR ↗

9:28 AM ET 8-K
Court & Legal Update

Cardiff Oncology Court & Legal Update

Cardiff Oncology entered into a confidential settlement agreement with Nerviano Medical Sciences to resolve litigation in the U.S. District Court for the Southern District of California regarding patent inventorship and license performance. As part of the settlement, the parties amended their 2017 license agreement for onvansertib, updating the royalty structure, exclusivity framework, and granting Nerviano a board observer seat. No monetary payments were made by either party to settle the litigation, which will be dismissed with prejudice.

Counterparty
Nerviano Medical Sciences, S.r.l.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.